Cargando…
Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma
OBJECTIVE: To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin to radiotherapy confers an advantage for overall survival (OAS), and progression free survival (PFS); to assess the incidence of relapses over standard pelvic radiotherapy; and to evaluate the related toxi...
Autores principales: | El-Hadaad, Hend Ahmed, Wahba, Hanan Ahmed, Gamal, Anas Mohamed, Dawod, Tamer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643665/ https://www.ncbi.nlm.nih.gov/pubmed/23691474 http://dx.doi.org/10.7497/j.issn.2095-3941.2012.03.003 |
Ejemplares similares
-
Current approaches in treatment of triple-negative breast cancer
por: Wahba, Hanan Ahmed, et al.
Publicado: (2015) -
Sequential Chemoradiotherapy Compared to Radiotherapy in Endometrial Carcinoma
por: Elemam, Omima, et al.
Publicado: (2020) -
A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
por: Onal, Cem, et al.
Publicado: (2018) -
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer
por: Signorelli, Mauro, et al.
Publicado: (2015) -
Adjuvant chemoradiotherapy versus chemotherapy or radiotherapy in advanced endometrial cancer: a systematic review and meta-analysis
por: Winarto, Hariyono, et al.
Publicado: (2022)